The Journal of Immunology, Vol 157, Issue 12 5367-5374, Copyright © 1996 by American Association of Immunologists

ARTICLES

Biochemical and serologic evidence for the existence of functionally distinct forms of the CD94 NK cell receptor

JJ Perez-Villar, M Carretero, F Navarro, I Melero, A Rodriguez, C Bottino, A Moretta and M Lopez-Botet
Immunology Service, Hospital de la Princesa, Autonomous University of Madrid, Spain.

The CD94 NK cell receptor is assembled as a disulfide-linked dimer and appears to be encoded by a single-copy gene of the C-type lectin superfamily. In reverse Ab-dependent cellular cytotoxicity assays, CD94- specific mAbs may either trigger or inhibit cytotoxicity in distinct subsets of NK clones, termed groups A and B, respectively. The molecular basis for this functional ambivalence of CD94 has been addressed. CD94 molecules immunoprecipitated with the HP-3B1 mAb from the two different subsets of NK clones were comparatively analyzed by SDS-PAGE. Under reducing conditions, the stimulating form of CD94 from group A clones displayed a significantly lower Mr (39 kDa) than the inhibitory form of group B clones (Mr = 43 kDa). Analyses of N- glycanase and V8 protease-digested samples indicated that the two CD94 forms are homologous. A CD94-specific mAb (Z199) that did not recognize cells transfected with a CD94 cDNA (LL288) was characterized. Z199 did not bind to group A clones, whereas its reactivity with group B NK cells was indistinguishable from that of other CD94-specific mAbs. Different from the HP-3B1 mAb, the Z199 mAb displayed only inhibitory effects in reverse Ab-dependent cellular cytotoxicity assays. Immunoprecipitation studies confirmed that Z199 selectively identified the 43-kDa CD94. Our study proves the existence of at least two biochemically and serologically distinct CD94 molecules, whose selective/predominant expression at the clonal level correlates with the pattern of response (i.e., inhibition vs activation) of NK cells to ligation by CD94-specific mAbs.

This article has been cited by other articles:

				C.-W. Lin, Y.-H. Chen, Y.-C. Chuang, T.-Y. Liu, and S.-M. Hsu CD94 transcripts imply a better prognosis in nasal-type extranodal NK/T-cell lymphoma Blood, October 1, 2003; 102(7): 2623 - 2631. [Abstract] [Full Text] [PDF]

				K. Khalturin, M. Becker, B. Rinkevich, and T. C. G. Bosch Urochordates and the origin of natural killer cells: Identification of a CD94/NKR-P1-related receptor in blood cells of Botryllus PNAS, January 21, 2003; 100(2): 622 - 627. [Abstract] [Full Text] [PDF]

				S. S. Farag, T. A. Fehniger, L. Ruggeri, A. Velardi, and M. A. Caligiuri Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect Blood, August 28, 2002; 100(6): 1935 - 1947. [Abstract] [Full Text] [PDF]

				A. King, L. Gardner, and Y.W. Loke Co-stimulation of human decidual natural killer cells by interleukin-2 and stromal cells Hum. Reprod., March 1, 1999; 14(3): 656 - 663. [Abstract] [Full Text] [PDF]

				N. Lee, M. Llano, M. Carretero, A. Ishitani, F. Navarro, M. Lopez-Botet, and D. E. Geraghty HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A PNAS, April 28, 1998; 95(9): 5199 - 5204. [Abstract] [Full Text] [PDF]

				S. D. Voss, J. Daley, J. Ritz, and M. J. Robertson Participation of the CD94 Receptor Complex in Costimulation of Human Natural Killer Cells J. Immunol., February 15, 1998; 160(4): 1618 - 1626. [Abstract] [Full Text] [PDF]

				O. Mandelboim, L. Pazmany, D. M. Davis, M. Vales-Gomez, H. T. Reyburn, B. Rybalov, and J. L. Strominger Multiple receptors for HLA-G on human natural killer cells PNAS, December 23, 1997; 94(26): 14666 - 14670. [Abstract] [Full Text] [PDF]